These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 847954)

  • 21. The viability of hemodialysis as a treatment option for renal failure in a developing economy.
    Arije A; Kadiri S; Akinkugbe OO
    Afr J Med Med Sci; 2000; 29(3-4):311-4. PubMed ID: 11714013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting hemodialysis access failure with the measurement of dialysis access recirculation.
    Salimi J; Razeghi E; Karjalian H; Meysamie A; Dahhaz M; Dadmehr M
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):781-4. PubMed ID: 18711295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between body mass index and body fat in chronic kidney disease stages 3 to 5, hemodialysis, and peritoneal dialysis patients.
    Leinig C; Pecoits-Filho R; Nascimento MM; Gonçalves S; Riella MC; Martins C
    J Ren Nutr; 2008 Sep; 18(5):424-9. PubMed ID: 18721737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Morphologic studies of the liver in patients in the terminal stage of chronic renal insufficiency].
    Bialik VL; Kozyr' VI; Ryb'iakova EG
    Vrach Delo; 1972 Nov; 11():82-5. PubMed ID: 4659749
    [No Abstract]   [Full Text] [Related]  

  • 25. Diuretic effect and pharmacokinetic data observed at different stages of chronic renal failure with 240 mg of muzolimine.
    Baumelou A; Singlas E; Ritter W; Merdjan H; Martre H; Brouard R; Chickh-Touami C; Patte R
    Z Kardiol; 1985; 74 Suppl 2():88-91. PubMed ID: 4002810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Activity of plasma renin in patients with terminal renal insufficiency kept on chronic hemodialysis].
    Lifshits NL; Ermolenko VM; Sumarokov AV; Tatsievskiĭ VA; Kondakhchan MA
    Ter Arkh; 1975; 47(4):81-8. PubMed ID: 1145487
    [No Abstract]   [Full Text] [Related]  

  • 27. [Arterial hypertension in chronic kidney failure treated by extra-renal dialysis].
    Traeger J; Zech P; François B; Heydendael G; Moskovtchenko JF; Dubois Y; Pozet N; Sassard J
    Acquis Med Recent; 1969; ():261-96. PubMed ID: 5376775
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of human recombinant erythropoietin therapy on protein metabolism of patients with terminal renal failure on hemodialysis].
    Scigalla P; Fischer C; Park W; Becker H; Schiller R; Paust H; Brösicke H; Kessel M
    Beitr Infusionsther; 1990; 25():430-8. PubMed ID: 1690065
    [No Abstract]   [Full Text] [Related]  

  • 29. [Dialysis treatment is satisfactory. A survey of all patients with chronic renal failure in Stockholm].
    Elinder CG; Heimbürger O; Hylander B; Warholm C; Bergström J
    Lakartidningen; 1995 May; 92(22):2316-20. PubMed ID: 7783494
    [No Abstract]   [Full Text] [Related]  

  • 30. [The effect of dialysis membranes on lipid peroxidation in erythrocytes of patients with terminal renal failure].
    Kubatiev AA; Rud'ko IA; Balashova TS; Ermolenko VM
    Biull Eksp Biol Med; 1994 Nov; 118(11):460-2. PubMed ID: 7888639
    [No Abstract]   [Full Text] [Related]  

  • 31. Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
    Migliacci R; Falcinelli F; Imperiali P; Floridi A; Nenci GG; Gresele P
    Ital Heart J; 2004 May; 5(5):371-7. PubMed ID: 15185901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of hemodialysis on the ATP blood level in patients with chronic kidney failure treated with hemodialysis].
    Caban M; Smoleński O; Barylak H; Kutrzeba W
    Pol Tyg Lek; 1977 Aug; 32(35):1369. PubMed ID: 896592
    [No Abstract]   [Full Text] [Related]  

  • 33. [The crythrocyte system in terminal renal failure caused by chronic glomerulonephritis, treated by hemodialysis].
    Dobiecka-Wawrzecka B
    Wiad Lek; 1980 Jun; 33(11):849-54. PubMed ID: 7423987
    [No Abstract]   [Full Text] [Related]  

  • 34. [Course of heart failure in patients with terminal chronic kidney failure on chronic hemodialysis].
    En'kina TN; Riabov SI; Lukichev BG; En'kin AA; Grinev KM
    Ter Arkh; 2001; 73(6):15-20. PubMed ID: 11521514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of programmed hemodialysis on the absorptive-excretory function of the liver in terminal chronic renal insufficiency].
    Kozyr' VI
    Vrach Delo; 1975 Jun; (6):41-3. PubMed ID: 1154735
    [No Abstract]   [Full Text] [Related]  

  • 36. [Intermittent haemodialysis by the Scribner-Kiil method in chronic terminal renal insufficiency. Preliminary trials].
    Bandier E; Krogsgaard AR; Ladehoff A; Larsen NA; Madsen PC; Nielsen B; Raaschou F; Willumsen J
    Ugeskr Laeger; 1968 Oct; 130(41):1711-24. PubMed ID: 5724706
    [No Abstract]   [Full Text] [Related]  

  • 37. [Iron metabolism in patients in kidney failure dialysis treatment].
    Zadrazil J; Bachleda P; Papajík T; Scudla V; Zahálková J; Budíková M; Novotný D
    Acta Univ Palacki Olomuc Fac Med; 1993; 135():95-7. PubMed ID: 7976690
    [No Abstract]   [Full Text] [Related]  

  • 38. [Intermittent hemodialysis in terminal chronic nephropathy in Fredericia Hospital].
    Birkeland SA; Hoffmeyer J; Rojel J
    Ugeskr Laeger; 1969 Mar; 131(12):511-9. PubMed ID: 5793607
    [No Abstract]   [Full Text] [Related]  

  • 39. [Von Willebrand factor in hemodialysed patients with chronic renal failure].
    Bronisz M; Rość D; Paczuski R; Nartowicz E; Bronisz A
    Pol Merkur Lekarski; 2001 Jul; 11(61):40-3. PubMed ID: 11579829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of chronic intermittent hemodialysis in the treatment of patients with chronic renal failure].
    Smetisko A; Cecuk L; Thune S
    Lijec Vjesn; 1973 Jul; 95(7):400-3. PubMed ID: 4742197
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.